SFX by Ex Libris Inc.

Title:	Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model
Source:	Human Molecular Genetics [0964-6906] Aikawa, T yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Clark, I A. "Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease." British Journal of Pharmacology 172.15 (2015): 3714-27.
description	2.	Green, Kim N. "Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology." Brain 139.4 (2016): 1265-1281.
description	3.	De Strooper, B. "The Cellular Phase of Alzheimer's Disease." Cell 164.4 (2016): 603-15.
description	4.	Heneka, Michael T. "Innate immune activation in neurodegenerative disease." Nature reviews. Immunology 14.7 (2014): 463-477.
description	5.	Mullane, K. "Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?" Biochemical pharmacology 85.3 (2013): 289-305.
description	6.	Heneka, Michael T. "NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice." Nature 493.7434 (2012): 674-8.
description	7.	Russo, Matthew V. "Inflammatory neuroprotection following traumatic brain injury." Science 353.6301 (2016): 783-785.
description	8.	Richards, Robert I. "The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease." Frontiers in neuroscience 10.MAY (2016): 193-193.
description	9.	Tian, M. "Association of IL-1, IL-18, and IL-33 gene polymorphisms with late-onset Alzheimer׳s disease in a Hunan Han Chinese population." Brain research 1596 (2015): 136-145.
description	10.	Hardy, J. "Apolipoprotein E in Alzheimer's Disease: An Update." Annual Review of Neuroscience 37.1 (2014): 79-100.
description	11.	Pimplikar, SW W. "Reassessing the amyloid cascade hypothesis of Alzheimer's disease." The international journal of biochemistry & cell biology 41.6 (2008): 1261-1268.
description	12.	Brawek, B. "Network-wide dysregulation of calcium homeostasis in Alzheimer's disease." Cell and tissue research 357.2 (2014): 427-38.
description	13.	De Paula, Vanessa J. "Alzheimer's disease." Subcellular Biochemistry 65 (2012): 329-352.
description	14.	Ramos, Francesc X. "Modification of γ-secretase by nitrosative stress links neuronal aging to sporadic alzheimer's disease." EMBO molecular medicine 4.7 (2012): 660-673.
description	15.	Fox, Nick C. "Suspected early dementia." BMJ. British medical journal 343.20 (2011).
description	16.	Gorelick, Philip B. "Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association." Stroke 42.9 (2011): 2672-2713.
description	17.	Sisodia, S. "Amyloid beta from axons and dendrites reduces local spine number and plasticity." Nature Neuroscience 13.2 (2009): 190-196.
description	18.	Lawrence, CB. "Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat." The European journal of neuroscience 10.3 (1998): 1188-1195.
description	19.	McCarty, M F F. "High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes." Medical Hypotheses 52.5 (1999): 401-6.
description	20.	Suzumura, A. "Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner." The Journal of biological chemistry 281.30 (2006): 21362-8.